Torren Management’s Pfizer PFE Stock Holding History

Torren Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,374	Closed	-$34.2K	–	1316
2025 Q4	$34.2K	Buy	+1,374	New	+$34.6K	0.02%	440

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Torren Management's PFE Position: Q1 2026 in Review

Torren Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 1,374 shares — an estimated $34.2K sold.

Torren Management first reported a position in PFE in Q4 2025 and held it in 1 quarter. The position peaked at $34.2K in Q4 2025. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Torren Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
Torren Management sold 1,374 Pfizer shares in Q1 2026, an estimated $34.2K.
Torren Management first reported a position in Pfizer in Q4 2025 and held it in 1 quarter.
Torren Management's Pfizer position peaked at $34.2K in Q4 2025.
2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.